Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to compare the effectiveness of an ayahuasca-assisted constructivist therapy with constructivist therapy and no treatment to decrease the severity of grief. A secondary purpose is to assess the effectiveness to prevent Persistent Complex Bereavement Disorder and Prolonged Grief Disorder, and to assess potential changes in avoidance, meaning-making and self-clarity. Subjective effects and Acceptance promoting effects of psychedelic drug are assessed after ayahuasca administration. A non-randomized controlled trial is proposed with three arms involving an experimental group (ayahuasca in concert with psychotherapy) and two control groups (psychotherapy and no treatment) with pretest, posttest and 3 months follow-up.


Clinical Trial Description

Grief is a deep and intense sorrow caused by the loss of someone loved. Although every person could benefit from support, only a substantial minority of bereaved people experience severe, persistent and disabling grief (PCBD), requiring treatment one year after the death of a loved one. However, pharmacotherapy alone has not proven to be effective, and while psychological interventions for prolonged grief disorder may be efficacious, the clinical effectiveness is small (Hedges' g: 0.41-0.45). As far as we know, no bereavement prevention program has proven to be effective, and early interventions are discouraged. Thus, there are no effective resources for supporting the bereaved during the months following the death of a loved one, a need which peaks during the months following the death, when grief is most intense and the bereaved lives are at their highest level of risk. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06150859
Study type Interventional
Source Beckley Med Foundation
Contact
Status Enrolling by invitation
Phase Phase 2
Start date October 15, 2021
Completion date June 15, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05867706 - Caregiver Burden and Bereavement-related Distress
Completed NCT02886052 - Internet-based Cognitive Behavior Therapy for Insomnia for Parents Who Have Lost a Child N/A
Completed NCT01453699 - Long-term Consequences of Bereavement in Children, Adolescents and Young Adults N/A
Completed NCT05655741 - Modified Delphi for Genomic Bereavement Care
Completed NCT00001913 - The Impact of Familiarity and Emotional Attachment on the Visual Processing of Faces N/A
Completed NCT04254718 - Digital Storytelling in the NICU N/A
Completed NCT02631291 - Promoting Widowed Elders Lifestyle After Loss N/A
Recruiting NCT06191484 - Risk and Resilience to Suicide Following Late-Life Spousal Bereavement N/A
Completed NCT05156346 - Pragmatic RCT to Assess the Effectiveness of an Online Self-help Programme for Older Adults After Spousal Bereavement N/A
Completed NCT02112084 - An Individualized Grief Intervention for Spouses of Cancer Patients After the Patient's Death N/A
Recruiting NCT06047808 - Feasibility Study of the Storytelling Through Music Intervention With Bereaved Parents N/A
Recruiting NCT06136260 - The Missing Pieces Trial: A Comparison of Two Interventions to Support Parents After Their Child's Unexpected or Traumatic Death N/A
Recruiting NCT05142605 - Evaluation of Grief Therapy Approaches for Bereaved Parents Phase 2
Completed NCT04929405 - Pilot Testing ADAPT a Bereavement Care Intervention N/A
Enrolling by invitation NCT06302283 - Collateral Effects of Pandemics - Care for Informal Caregivers
Completed NCT02672800 - A Psychosocial Intervention for Bereaved Spousal Caregivers of Persons With Dementia N/A
Completed NCT01179568 - A Study of Medication With or Without Psychotherapy for Complicated Grief Phase 2
Completed NCT04505904 - Oxytocin and Approach-avoid in Grief N/A
Completed NCT04602520 - Preserving Compassionate End of Life Care in the Pandemic
Recruiting NCT05803499 - Rest to Overcome Loss and Reduce Risk N/A